SURF NASDAQ
Surface Oncology, Inc.
1W: +5.9%
1M: +11.5%
3M: +39.5%
1Y: -21.9%
3Y: -83.9%
5Y: -89.6%
$1.07
Last traded 2023-09-12 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships0
As Filer
counterparties named
3
As Counterparty
mentioned by others
2023-06-16
Earliest Filing
2024-06-27
Latest Filing
Mentioned As Counterparty
3 mentionsOther companies that named SURF in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| CHRS Coherus BioSciences, Inc. | acquirer | Target of the Surface Merger acquired by Coherus BioSciences, Inc. | 2024-06-27 | View |
| CHRS Coherus BioSciences, Inc. | acquirer | Target company acquired via merger agreement effective September 8, 2023. | 2023-09-08 | View |
| CHRS Coherus BioSciences, Inc. | acquirer | Target company in the merger agreement with Coherus BioSciences, Inc. | 2023-06-16 | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR